1. Home
  2. STTK vs ATLO Comparison

STTK vs ATLO Comparison

Compare STTK & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$3.30

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$22.93

Market Cap

203.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
ATLO
Founded
2016
1903
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
203.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
STTK
ATLO
Price
$3.30
$22.93
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
424.7K
27.4K
Earning Date
11-06-2025
01-23-2026
Dividend Yield
N/A
3.47%
EPS Growth
N/A
82.57
EPS
N/A
1.80
Revenue
$1,000,000.00
$60,568,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$12.85
Revenue Growth
N/A
18.60
52 Week Low
$0.69
$16.04
52 Week High
$3.38
$24.36

Technical Indicators

Market Signals
Indicator
STTK
ATLO
Relative Strength Index (RSI) 71.09 59.46
Support Level $2.82 $22.89
Resistance Level $3.29 $24.12
Average True Range (ATR) 0.24 0.53
MACD -0.00 -0.08
Stochastic Oscillator 82.14 48.80

Price Performance

Historical Comparison
STTK
ATLO

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

Share on Social Networks: